VLNS.TO
Valens Company Inc.
Price:  
1.01 
CAD
Volume:  
59,486.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VLNS.TO Intrinsic Value

109,882.30 %
Upside

What is the intrinsic value of VLNS.TO?

As of 2025-04-22, the Intrinsic Value of Valens Company Inc. (VLNS.TO) is 1,110.82 CAD. This VLNS.TO valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 1.01 CAD, the upside of Valens Company Inc. is 109,882.30%.

The range of the Intrinsic Value is 565.22 - 1,709.73 CAD

Is VLNS.TO undervalued or overvalued?

Based on its market price of 1.01 CAD and our intrinsic valuation, Valens Company Inc. (VLNS.TO) is undervalued by 109,882.30%.

1.01 CAD
Stock Price
1,110.82 CAD
Intrinsic Value
Intrinsic Value Details

VLNS.TO Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (12,251.05) - (3,722.25) (5,656.87) -560186.3%
DCF (Growth 10y) (14,675.68) - (51,034.39) (22,927.56) -2270155.8%
DCF (EBITDA 5y) 565.22 - 1,709.73 1,110.82 109882.3%
DCF (EBITDA 10y) 3,786.25 - 11,959.14 7,482.28 740719.3%
Fair Value -14.59 - -14.59 -14.59 -1,544.08%
P/E (60.38) - (63.36) (61.48) -6186.8%
EV/EBITDA (8.03) - 323.74 126.82 12456.4%
EPV (2.62) - (3.39) (3.00) -397.2%
DDM - Stable (28.25) - (116.74) (72.49) -7277.4%
DDM - Multi (83.14) - (270.52) (127.62) -12735.2%

VLNS.TO Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 81.55
Beta 1.81
Outstanding shares (mil) 80.74
Enterprise Value (mil) 120.20
Market risk premium 5.10%
Cost of Equity 8.74%
Cost of Debt 5.00%
WACC 8.09%